Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Juvenile Dermatomyositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03433638
Recruitment Status : Unknown
Verified February 2018 by University Hospital, Strasbourg, France.
Recruitment status was:  Recruiting
First Posted : February 14, 2018
Last Update Posted : February 27, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.

Condition or disease
Juvenile Dermatomyositis

Layout table for study information
Study Type : Observational
Estimated Enrollment : 22 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Descriptive Study of Juvenile Dermatomyositis in Alsace
Actual Study Start Date : February 8, 2018
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2019





Primary Outcome Measures :
  1. Study of clinical characteristics of juvenile dermatomyositis [ Time Frame: The period from from January 1st, 2000 to December 31st, 2015 will be examined ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Patient who have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975
Criteria

Inclusion Criteria:

  • Age under 16 years
  • Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975

Exclusion Criteria:

  • Refusal to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03433638


Contacts
Layout table for location contacts
Contact: Dan LIPSKER, MD, PhD 33.3.88.11.61.79 dan.lipsker@chru-strasbourg.fr
Contact: Céline RAMSTEIN, MD 33.3.88.11.61.79 celine.ramstein@chru-strasbourg.fr

Locations
Layout table for location information
France
Service de Dermatologie Recruiting
Strasbourg, France, 67091
Contact: Dan LIPSKER, MD, PhD    33.3.88.11.61.79    dan.lipsker@chru-strasbourg.fr   
Contact: Céline Ramstein, MD    33.3.88.11.61.79    celine.ramstein@chru-strasbourg.fr   
Principal Investigator: Dan LIPSKER, MD, PhD         
Sub-Investigator: Céline Ramstein, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France

Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03433638    
Other Study ID Numbers: 6785
First Posted: February 14, 2018    Key Record Dates
Last Update Posted: February 27, 2018
Last Verified: February 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Juvenile dermatomyositis
Inflammatory myopathy
Clinical features
Treatment
Additional relevant MeSH terms:
Layout table for MeSH terms
Dermatomyositis
Polymyositis
Myositis
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Connective Tissue Diseases
Skin Diseases